Synergistic anticancer effects of carrier-free self-assembled doxorubicin and emodin nanoparticles in non-small cell lung cancer

Abstract To develop excipient-free carrier-free nanoparticles (DE NPs) via self-assembly of doxorubicin (DOX) and emodin (EMO) for enhanced combination chemotherapy against non-small cell lung cancer (NSCLC). DE NPs were fabricated through non-covalent interactions between DOX and EMO using a self-a...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Cheng Tang, Yangyang Zou, Hao Meng, Jin Xu, Fang Long, Xiaoli Chen, Qingling Xiao, Kelei Su, Zhang Nan, Yaoyao Guo, Chaojuan Li
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2025-11-01
Colecção:	Scientific Reports
Assuntos:	Doxorubicin Emodin Carrier-free nanodrug Synergistic therapy Non-small cell lung cancer
Acesso em linha:	https://doi.org/10.1038/s41598-025-24027-2
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!